Manu Ohri - 15 Jul 2022 Form 4 Insider Report for GT Biopharma, Inc. (GTBP)

Role
CFO & Secretary
Signature
/s/ Manu Ohri
Issuer symbol
GTBP
Transactions as of
15 Jul 2022
Net transactions value
$0
Form type
4
Filing time
19 Jul 2022, 21:44:26 UTC
Previous filing
18 Feb 2022
Next filing
01 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTBP Common Stock Award $0 +100,000 $0.000000 100,000 15 Jul 2022 Direct
transaction GTBP Common Stock Other $0 -100,000 -100% $0.000000* 0 15 Jul 2022 Direct F1
transaction GTBP Common Stock Other $0 +100,000 $0.000000 100,000 15 Jul 2022 By Anarjay Concepts, Inc. F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTBP Option to purchase Common Stock Award $0 +200,000 $0.000000 200,000 15 Jul 2022 Common Stock 200,000 $2.48 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person transferred the shares without consideration to Anarjay Concepts, Inc., a corporation wholly-owned by the reporting person.
F2 66,666 shares on the date of grant, and 66,667 shares on each February 14, 2023 and 2024.